These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Secondary prevention of TIA and stroke. How much must thrombocytes not be inhibited?]. Einecke D. MMW Fortschr Med; 2004 Jun 10; 146(24):50. PubMed ID: 15366495 [No Abstract] [Full Text] [Related]
3. [Clopidogrel protection is not increased further by ASS!]. Bogousslavsky J. Praxis (Bern 1994); 2004 Aug 25; 93(35):1390. PubMed ID: 15468578 [No Abstract] [Full Text] [Related]
4. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy. Biller J. J Neurol Sci; 2009 Sep 15; 284(1-2):1-9. PubMed ID: 19380153 [Abstract] [Full Text] [Related]
5. [The combination of acetylsalicylic acid and dipyridamole is more effective in secondary prevention following transient ischaemic attack or cerebral infarction: the debate is closed]. Offerhaus L. Ned Tijdschr Geneeskd; 2006 Dec 02; 150(48):2673; author reply 2673-4. PubMed ID: 17205947 [No Abstract] [Full Text] [Related]
6. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial. Serebruany VL, Malinin AI, Pokov AN, Hanley DF. Clin Ther; 2008 Feb 02; 30(2):249-59. PubMed ID: 18343263 [Abstract] [Full Text] [Related]
7. [The combination of acetylsalicylic acid and dipyridamole is more effective in secondary prevention following transient ischaemic attack or cerebral infarction: the debate is closed]. Schrama E, Eusman JP. Ned Tijdschr Geneeskd; 2006 Dec 02; 150(48):2672; author reply 2672-3. PubMed ID: 17205946 [No Abstract] [Full Text] [Related]
8. Antiplatelet treatment for secondary prevention of acute ischemic stroke and transient ischemic attacks: mechanisms, choices and possible emerging patterns of use. Moonis M, Fisher M. Expert Rev Cardiovasc Ther; 2003 Nov 02; 1(4):611-5. PubMed ID: 15030260 [No Abstract] [Full Text] [Related]